Uitdehaag, Bernard

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., et al. (2018) · The Lancet Neurology

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 8,167

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

International MS Genetics Consortium, De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I. W., Ottoboni, L., Aggarwal, N. T., Piccio, L., Raychaudhuri, S., Tran, D., et al. (2009) · Nature Genetics

Multiple Sclerosis Research StudiesGenetic Associations and Epidemiology

Cited by 800

Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis

Boeschoten, R. E., Braamse, A. M. J., Beekman, A. T. F., Cuijpers, P., van Oppen, P., Dekker, J., & Uitdehaag, B. M. J. (2017) · Journal of the Neurological Sciences

Multiple Sclerosis Research StudiesCancer survivorship and care

Cited by 713

Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages

Huitinga, I., van Rooijen, N., de Groot, C. J., Uitdehaag, B. M., & Dijkstra, C. D. (1990) · The Journal of experimental medicine

Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms

Cited by 506

Pathway and network-based analysis of genome-wide association studies in multiple sclerosis

Baranzini, S. E., Galwey, N. W., Wang, J., Khankhanian, P., Lindberg, R., Pelletier, D., Wu, W., Uitdehaag, B. M. J., Kappos, L., GeneMSA Consortium, et al. (2009) · Human Molecular Genetics

Multiple Sclerosis Research StudiesBioinformatics and Genomic Networks

Cited by 383

Bright Light Treatment in Elderly Patients With Nonseasonal Major Depressive Disorder: A Randomized Placebo-Controlled Trial

Lieverse, R., Van Someren, E. J. W., Nielen, M. M. A., Uitdehaag, B. M. J., Smit, J. H., & Hoogendijk, W. J. G. (2011) · Archives of General Psychiatry

Circadian rhythm and melatoninTreatment of Major Depression

Cited by 261

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: A phase 2b, randomised, double-blind, placebo-controlled trial

Reich, D. S., Arnold, D. L., Vermersch, P., Bar-Or, A., Fox, R. J., Matta, A., Turner, T., Wallström, E., Zhang, X., Mareš, M., et al. (2021) · The Lancet Neurology

Multiple Sclerosis Research StudiesChronic Lymphocytic Leukemia Research

Cited by 204

Differentiation of Multiple Sclerosis from Other Inflammatory Disorders and Cerebrovascular Disease: Value of Spinal MR Imaging

Bot, J. C. J., Barkhof, F., à Nijeholt, G. L., van Schaardenburg, D., Voskuyl, A. E., Ader, H. J., Pijnenburg, J. A. L., Polman, C. H., Uitdehaag, B. M. J., Vermeulen, E. G. J., et al. (2002) · Radiology

Multiple Sclerosis Research StudiesAdvanced MRI Techniques and Applications

Cited by 168

Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis

Sombekke, M. H., Wattjes, M. P., Balk, L. J., Nielsen, J. M., Vrenken, H., Uitdehaag, B. M. J., Polman, C. H., & Barkhof, F. (2013) · Neurology

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 153

Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study

Filippi, M., Preziosa, P., Meani, A., Ciccarelli, O., Mesaros, S., Rovira, A., Frederiksen, J., Enzinger, C., Barkhof, F., Gasperini, C., et al. (2018) · The Lancet Neurology

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 124

Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria

Nielsen, J. M., Korteweg, T., Barkhof, F., Uitdehaag, B. M. J., & Polman, C. H. (2005) · Annals of Neurology

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 72

Association of Arachidonic Acid–Derived Lipid Mediators With Disease Severity in Patients With Relapsing and Progressive Multiple Sclerosis

Broos, J. Y., Loonstra, F. C., de Ruiter, L. R. J., Gouda, M., Fung, W. H., Schoonheim, M. M., Heijink, M., Strijbis, E. M. M., Teunissen, C., Killestein, J., et al. (2023) · Neurology

Multiple Sclerosis Research StudiesFatty Acid Research and Health

Cited by 29

Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis

Klauser, A. M., Wiebenga, O. T., Eijlers, A. J., Schoonheim, M. M., Uitdehaag, B. M., Barkhof, F., Pouwels, P. J., & Geurts, J. J. (2018) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesAdvanced MRI Techniques and Applications

Cited by 28